MyFinsight
Home
Blog
About
Contact
Non-cash interest
expense, inclusive of...
$7,084K
Accounts receivable,
inclusive of related party
-$6,771K
Change in fair value of
debt derivative...
-$3,155K
Depreciation
$2,310K
Stock-based compensation
$1,698K
Accounts payable
$1,427K
Inventory
-$930K
Other assets
-$209K
Net cash provided by
operating activities
$4,700K
Canceled cashflow
$18,884K
Revenues
$23,193K
Other income, net
$110K
Net increase
(decrease) in cash and cash...
$3,326K
Canceled cashflow
$1,374K
Net loss
-$14,980K
Accrued expenses and
other liabilities
-$3,652K
Contract assets
$206K
Other, net
$46K
Proceeds from revolving
credit facility
$36,400K
Canceled cashflow
$23,303K
Net cash (used in)
provided by investing...
-$1,118K
Net cash used in
financing activities
-$256K
Canceled cashflow
$36,400K
Personnel costs
$11,895K
Materials and
non-depreciation overhead
$8,856K
Interest expense, net
-$7,220K
Change in fair value of
debt derivative...
-$3,155K
Depreciation
$2,310K
Stock-based compensation
$1,698K
All other operating
expenses
$1,563K
Reorganization costs
$1,543K
Income tax expense
(benefit)
$43K
Purchases of property,
plant, and equipment
$1,118K
Payments on revolving
credit facility
$36,400K
Other financing
activities
-$256K
Back
Back
Cash Flow
LIFECORE BIOMEDICAL, INC. DE (LFCR)
LIFECORE BIOMEDICAL, INC. DE (LFCR)
source: myfinsight.com